Serum levels of tissue inhibitor of metalloproteinase‐1 are correlated with liver fibrosis in patients with chronic hepatitis B
Authors:
- 31 July 2012
- journal article
- research article
- Published by Wiley in Journal of Digestive Diseases
- Vol. 13 (11) , 558-563
Abstract
Objective: To investigate the relationship between tissue inhibitor of metalloproteinase‐1 (TIMP‐1) expression and the severity of liver fibrosis in chronic hepatitis B (CHB) patients, and to explore the diagnostic value of serum TIMP‐1.Methods: A total of 159 CHB patients underwent liver biopsy for the analysis of liver fibrosis stages and inflammation. Serum TIMP‐1 was determined by ELISA. Hyaluronic acid (HA), procollagen type III (PCIII), collagen type IV (CIV), laminin (LN), and FIB‐4 index were determined and calculated, and diagnostic accuracy was analyzed using receiver operating characteristic (ROC) curve.Results: Serum levels of TIMP‐1 were associated with the grade of liver inflammation in CHB patients (r = 0.695, P < 0.01), especially in those without fibrosis or with stage 1 fibrosis, and were also positively correlated with liver fibrosis in CHB patients (r = 0.854, P < 0.01), particularly in those with inflammation at grade 1, 2 and 3. The area under the ROC curve (AUROC) of serum TIMP‐1 was 0.918 for significant liver fibrosis (≥stage 2), and a sensitivity of 89.4% and specificity of 83.6% were obtained with a cut‐off value of ≥174.5 ng/mL of serum TIMP‐1, which were higher than that of HA, CIV and FIB‐4 index.Conclusion: TIMP‐1 is a valuable single biomarker for the evaluation of significant fibrosis in CHB patients.Keywords
This publication has 28 references indexed in Scilit:
- Therapeutic targets in liver fibrosisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Is HMGB1 a New Indirect Marker for Revealing Fibrosis in Chronic Hepatitis and a New Therapeutic Target in Treatment?Viral Immunology, 2010
- Accelerated liver fibrosis in hepatitis B virus transgenic mice: Involvement of natural killer T cellsHepatology, 2010
- Tumour necrosis factor-α levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scoresInternational Journal Of Clinical Practice, 2006
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- Prediction of significant fibrosis in HBeAg‐positive patients with chronic hepatitis B by a noninvasive model†Hepatology, 2005
- TNF-α and IL-1β–mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cellsKidney International, 2004
- Liver fibrosis – from bench to bedsideJournal of Hepatology, 2003
- Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive modelHepatology, 2002
- Tissue Inhibitor of Metalloproteinases–1 Promotes Liver Fibrosis Development in A Transgenic Mouse ModelHepatology, 2000